Mesothelioma patients can find relief from painful symptoms with natural treatments like acupuncture, aromatherapy, meditation, and dietary supplements. That said, patients should speak with doctors to make sure that natural treatments will be helpful. While natural treatments can ease pain, standard cancer treatments offer the best chance for long-term survival. Natural Treatments for Mesothelioma Explained…
Blog
Clinical Trial Recruiting Mesothelioma Patients to Undergo Immunotherapy Treatment MesoPher
Amphera, a Dutch biotechnology company has been developing a new immunotherapy drug for pleural mesothelioma — MesoPher. In March 2019, the company announced they have recruited the first patients to participate in their Phase 2/3 study to investigate MesoPher as a second-line treatment option for pleural mesothelioma. Currently, chemotherapy using a mixture of Alimta® (pemetrexed)…
Pacific Mesothelioma Center Receives Patent for Mesothelioma Stem Cell Therapy
The Pacific Mesothelioma Center (PMC) in Los Angeles, California has been issued a U.S. patent for a new treatment—mesothelioma stem cell therapy. The center at the Pacific Heart, Lung and Blood Institute can now offer mesenchymal stem cell treatment and clinical research opportunities to patients with pleural mesothelioma. New Treatments Provide New Hope Stem cell…
Upcoming Annual International Mesothelioma Symposium
The annual International Symposium on Malignant Mesothelioma is coming up — March 25-27, 2019, in Bethesda, MD. This mesothelioma symposium brings together mesothelioma patients, their families, doctors, and scientists and allows the community to learn about the latest research from the individuals conducting it. The Mesothelioma Symposium is an essential event for the research community…
Phase 3 Clinical Trial for Gene Therapy Recruiting Mesothelioma Patients
News of a new phase 3 Study may bring hope to pleural mesothelioma patients across the world who have stopped responding to standard chemotherapy. Trizell Ltd. recently announced that is has opened a phase 3 study of their promising new gene therapy for pleural mesothelioma, TR002. The current first-line and only approved drug therapy option…
Keytruda and Immunotherapy Drugs for Mesothelioma and Lung Cancer
Using Keytruda to treat lung cancer was recently approved in the European Union after a study demonstrated that this immunotherapy drug reduced the risk of death by 36%. Cancer is a devastating disease, and in Europe, lung cancer is one of the most deadly forms of the disease. “Lung cancer is the leading cause of…
Preclinical Trial for New Mesothelioma Drug Receives EU Funding
The European Union (EU) has awarded Aromics — a Spanish biotechnology company — €1 million (Euros) for its BERMES project that’s working on a novel mesothelioma drug. These funds will allow the company to finish its preclinical trials for this new drug, NAX035. The medical community needs to find effective targeted mesothelioma therapies because the…
First Mesothelioma Patient Undergoes “CA-170” Immunotherapy Drug in Clinical Trial
A mesothelioma patient has received a first dose of the CA-170 immunotherapy drug in a Phase 1 trial looking at patients with various advanced tumors and lymphomas, including a mesothelioma cohort (a group of mesothelioma patients). Curis, Inc. — a biotechnology company that focuses on treatments for cancer — announced that the first mesothelioma patient…
Revolutionary Cancer Breath Test Moves to Clinical Trials
Researchers at the Cancer Research UK Cambridge Center are currently recruiting the first participants for a new clinical trial to develop a cancer breath test. The breath test could aid in the early detection of multiple cancers and reduce the need for invasive diagnostic procedures like surgical biopsies. How Cancer Breath Testing Works Researchers are…